Home/Filings/4/0001567619-19-017673
4//SEC Filing

Weinreb Mark 4

Accession 0001567619-19-017673

CIK 0001505497other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 4:15 PM ET

Size

22.4 KB

Accession

0001567619-19-017673

Insider Transaction Report

Form 4
Period: 2019-08-27
Weinreb Mark
DirectorCEO and Chairman of the Board10% Owner
Transactions
  • Purchase

    Common Stock

    2019-08-29$0.26/sh+2,500$65892,500 total
  • Purchase

    Common Stock

    2019-08-27$0.25/sh+2,500$62587,500 total
  • Purchase

    Common Stock

    2019-08-27$0.26/sh+2,500$65090,000 total
  • Purchase

    Common Stock

    2019-08-29$0.27/sh+2,500$67595,000 total
Holdings
  • Stock Option

    Exercise: $0.75From: 2010-12-15Exp: 2020-12-14Common Stock (4,000 underlying)
    4,000
  • Stock Option

    Exercise: $0.75Exp: 2024-10-23Common Stock (150,000 underlying)
    150,000
  • Stock Option

    Exercise: $0.75Exp: 2027-06-23Common Stock (275,000 underlying)
    275,000
  • Stock Option

    Exercise: $0.75Exp: 2022-02-09Common Stock (50,000 underlying)
    50,000
  • Stock Option

    Exercise: $0.75Exp: 2025-09-04Common Stock (208,000 underlying)
    208,000
  • Stock Option

    Exercise: $0.75Exp: 2028-10-29Common Stock (275,000 underlying)
    275,000
  • Stock Option

    Exercise: $0.75Exp: 2026-06-10Common Stock (275,000 underlying)
    275,000
  • Stock Option

    Exercise: $0.75Exp: 2022-12-07Common Stock (20,000 underlying)
    20,000
  • Stock Option

    Exercise: $0.75Exp: 2024-02-18Common Stock (50,000 underlying)
    50,000
  • Stock Option

    Exercise: $0.75Exp: 2023-10-04Common Stock (12,500 underlying)
    12,500
Footnotes (9)
  • [F1]The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014.
  • [F2]The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013.
  • [F3]The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
  • [F4]The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016.
  • [F5]The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017.
  • [F6]The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018.
  • [F7]The option is exercisable to the extent of 91,667 shares on each of June 10, 2016 and June 10, 2017, and 91,666 shares on June 10, 2018.
  • [F8]The option is exercisable to the extent of 91,667 shares on each of June 23, 2017 and June 23, 2018, and 91,666 shares on June 23, 2019.
  • [F9]The option is exercisable to the extent of 91,667 shares on each of October 29, 2018 and October 29, 2019, and 91,666 shares on October 29, 2020.

Documents

1 file

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

Entity typeother

Related Parties

1
  • filerCIK 0001527212

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:15 PM ET
Size
22.4 KB